Ferroptosis: Frenemy of Radiotherapy
Overview
Chemistry
Molecular Biology
Affiliations
Recently, it was established that ferroptosis, a type of iron-dependent regulated cell death, plays a prominent role in radiotherapy-triggered cell death. Accordingly, ferroptosis inducers attracted a lot of interest as potential radio-synergizing drugs, ultimately enhancing radioresponses and patient outcomes. Nevertheless, the tumor microenvironment seems to have a major impact on ferroptosis induction. The influence of hypoxic conditions is an area of interest, as it remains the principal hurdle in the field of radiotherapy. In this review, we focus on the implications of hypoxic conditions on ferroptosis, contemplating the plausibility of using ferroptosis inducers as clinical radiosensitizers. Furthermore, we dive into the prospects of drug repurposing in the domain of ferroptosis inducers and radiosensitizers. Lastly, the potential adverse effects of ferroptosis inducers on normal tissue were discussed in detail. This review will provide an important framework for subsequent ferroptosis research, ascertaining the feasibility of ferroptosis inducers as clinical radiosensitizers.
Chen Y, Wang D, Luo H, Tan M, Wang Q, Wu X Mol Cell Biochem. 2025; .
PMID: 40087208 DOI: 10.1007/s11010-025-05240-z.
Bhange M, Telange D Discov Oncol. 2025; 16(1):77.
PMID: 39841330 PMC: 11754566. DOI: 10.1007/s12672-025-01821-y.
Exploring the Metabolic Impact of FLASH Radiotherapy.
Geirnaert F, Kerkhove L, Montay-Gruel P, Gevaert T, Dufait I, De Ridder M Cancers (Basel). 2025; 17(1.
PMID: 39796760 PMC: 11720285. DOI: 10.3390/cancers17010133.
Current advances on the role of ferroptosis in tumor immune evasion.
Gao C, Zhang H, Wang X Discov Oncol. 2024; 15(1):736.
PMID: 39621177 PMC: 11612115. DOI: 10.1007/s12672-024-01573-1.